Translational Cancer Research Group, Department of Clinical Medicine, Institute of Molecular Medicine, Trinity Centre for Health Sciences, St. James's Hospital, Dublin 8, Ireland.
Int J Biochem Cell Biol. 2009 Nov;41(11):2094-7. doi: 10.1016/j.biocel.2009.04.006. Epub 2009 Apr 16.
Hereditary hemochromatosis (HH) refers to a unique clinicopathologic subset of iron overload syndromes that includes the disorder related to C282Y homozygous mutation of the hemochromatosis protein (HFE), the most common form of hereditary hemochromatosis. Recent reports have highlighted analogies with the class of disorders, known as the conformational diseases whereby HFE C282Y mutant protein forms aggregates and is subsequently retained in the endoplasmic reticulum (ER). In conformational disorders, accumulation of unfolded or misfolded proteins in the ER can activate a complex cascade linked to the regulation of diverse physiologic processes, disease onset and progression. To-date, reviews on HFE C282Y HH have largely dealt with the end-stage consequence of this disorder (iron overload). However, our review focuses on upstream molecular events resulting from the mislocalization of the aggregation-prone HFE C282Y protein leading to potential advances in treatment and diagnosis.
遗传性血色素沉着症(HH)是一种独特的铁过载综合征的临床病理亚型,包括与血色素沉着症蛋白(HFE)C282Y 纯合突变相关的疾病,这是最常见的遗传性血色素沉着症形式。最近的报告强调了与一类被称为构象疾病的相似性,其中 HFE C282Y 突变蛋白形成聚集体,随后滞留在内质网(ER)中。在构象疾病中,未折叠或错误折叠的蛋白质在 ER 中的积累会激活与调节多种生理过程、疾病发作和进展相关的复杂级联反应。迄今为止,关于 HFE C282Y HH 的综述主要涉及该疾病(铁过载)的终末后果。然而,我们的综述重点关注由于易聚集的 HFE C282Y 蛋白定位错误而导致的上游分子事件,以期在治疗和诊断方面取得进展。